A. Rousseau

发表

Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer.

A. Larsen, I. Elalamy, G. Gerotziafas, 2017, International journal of oncology.

Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells.

A. Larsen, M. Sabbah, I. Elalamy, 2017, International journal of oncology.

Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

J. Daoud, M. Frikha, J. Gligorov, 2014, BMC Cancer.

Differential influence of breast cancer stage , time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

J. Daoud, M. Frikha, J. Gligorov, 2014 .

Persisting Endothelial Cell Activation and Hypercoagulability after COVID-19 Recovery—The Prospective Observational ROADMAP-Post COVID-19 Study

M. Dimopoulos, E. Terpos, M. Sabbah, 2022, Hemato.

Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor

D. Mottier, A. Delluc, G. Le Gal, 2011, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The procoagulant phospholipid dependent clotting time and the initiation phase of thrombin generation test are mandatory for the evaluation of the risk for severe early onset preeclampsia

P. van Dreden, A. Rousseau, E. Lefkou, 2022, Thrombosis Research.

Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction

M. Vasse, P. van Dreden, B. Lenormand, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia

P. Schneider, J. Vannier, M. Vasse, 2010, British journal of haematology.

Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin.

A. Larsen, I. Elalamy, E. Mbemba, 2015, Thrombosis research.

Comparative evaluation of Tissue factor and Thrombomodulin activity changes during normal and idiopathic early and late foetal loss: the cause of hypercoagulability?

R. Favier, P. van Dreden, A. Rousseau, 2012, Thrombosis research.

Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells.

A. Larsen, I. Elalamy, G. Gerotziafas, 2019, Thrombosis research.

Endothelial Cell Activation and Thrombin Generation Assessment for the Risk of Severe Early Onset Preeclampsia. the ROADMAP-EOP Study

I. Elalamy, G. Gerotziafas, A. Rousseau, 2022, Clinical and Applied Thrombosis/Hemostasis.

Decreased procoagulant phospholipids in patients treated by vitamin K antagonists.

M. Vasse, B. Lenormand, A. Rousseau, 2012, Thrombosis research.

Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia?

R. Favier, A. Rousseau, P. Van Dreden, 2009, European journal of obstetrics, gynecology, and reproductive biology.

Contribution of procoagulant phospholipids, thrombomodulin activity and thrombin generation assays as prognostic factors in intensive care patients with septic and non-septic organ failure

M. Vasse, J. Dreyfus, A. Rousseau, 2012, Clinical chemistry and laboratory medicine.

Clinical evaluation of a new functional test for detection of plasma procoagulant phospholipids

A. Rousseau, B. Woodhams, T. Exner, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Human seminal plasma fibrinolytic activity.

A. Rousseau, A. Carlo, P. Van Dreden, 2007, Seminars in thrombosis and hemostasis.

The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

M. Dimopoulos, E. Terpos, A. Falanga, 2022, Hemato.

Decreased activity of soluble thrombomodulin and plasma procoagulant phospholipids in childhood bone marrow transplantation with severe complications.

P. Schneider, E. Houivet, A. Marie‐Cardine, 2011, Thrombosis research.

Adherence with brand versus generic bisphosphonates among osteoporosis patients: a new-user cohort study in the French National Healthcare Insurance database

A. Schott, R. Chapurlat, P. Caillet, 2020, Scientific Reports.

Prevalence of antiphospholipid antibodies in psychiatric patients users and non‐users of antipsychotics

M. Walter, D. Mottier, A. Delluc, 2014, British journal of haematology.

Adherence with brand versus generic bisphosphonates among osteoporosis patients: a new-user cohort study in the French National Healthcare Insurance database

A. Schott, R. Chapurlat, P. Caillet, 2020, Scientific Reports.

Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction

M. Vasse, B. Lenormand, A. Savouré, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents

G. Gerotziafas, A. Rousseau, E. Lefkou, 2024, Thrombosis Research.